Showing results (221-230 of 246) with videos related to
Sort By:
Pageof 25
The EMBO Journal|October 1, 2020
Nox4 regulates InsP<sub>3</sub> receptor-dependent Ca<sup>2+</sup> release into mitochondria to promote cell survivalMatteo Beretta, Celio Xc Santos, Chris Molenaar, et al.Nature Communications|June 4, 2025
Reduction of SEM charging artefacts in native cryogenic biological samplesAbner Velazco, Thomas Glen, Sven Klumpe, et al.The Journal of Investigative Dermatology|January 15, 2016
Lentiviral Engineered Fibroblasts Expressing Codon-Optimized COL7A1 Restore Anchoring Fibrils in RDEBChristos Georgiadis, Farhatullah Syed, Anastasia Petrova, et al.Cell Reports|April 19, 2023
Multi-synaptic boutons are a feature of CA1 hippocampal connections in the stratum oriensMark Rigby, Federico W Grillo, Benjamin Compans, et al.Bioorganic & Medicinal Chemistry|June 5, 2007
Pyrrolidinones as orally bioavailable antagonists of the human melanocortin-4 receptor with anti-cachectic activityJoe A Tran, Fabio C Tucci, Wanlong Jiang, et al.Journal of Medicinal Chemistry|October 9, 2007
Discovery of 1-[2-[(1S)-(3-dimethylaminopropionyl)amino-2-methylpropyl]-4-methylphenyl]-4-[(2R)-methyl-3-(4-chlorophenyl)-propionyl]piperazine as an orally active antagonist of the melanocortin-4 receptor for the potential treatment of cachexiaChen Chen, Wanlong Jiang, Fabio Tucci, et al.EMBO Molecular Medicine|February 17, 2016
Wbp2 is required for normal glutamatergic synapses in the cochlea and is crucial for hearingAnnalisa Buniello, Neil J Ingham, Morag A Lewis, et al.ACS Infectious Diseases|July 30, 2021
Impacts of Metabolism and Organic Acids on Cell Wall Composition and <i>Pseudomonas aeruginosa</i> Susceptibility to Membrane Active AntimicrobialsGiorgia Manzo, Federico Gianfanti, Charlotte K Hind, et al.Scientific Reports|July 7, 2018
Cellular dissection of malaria parasite invasion of human erythrocytes using viable Plasmodium knowlesi merozoitesOliver Lyth, Gema Vizcay-Barrena, Katherine E Wright, et al.Journal of Medicinal Chemistry|October 29, 2008
Characterization of thien-2-yl 1S,2R-milnacipran analogues as potent norepinephrine/serotonin transporter inhibitors for the treatment of neuropathic painBrian Dyck, Junko Tamiya, Florence Jovic, et al.Pageof 25